search
Back to results

Spinal Anesthesia for External Cephalic Version

Primary Purpose

Breech Presentation; Before Labor

Status
Suspended
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Spinal Anaesthesia
Sponsored by
Region Skane
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breech Presentation; Before Labor focused on measuring breech presentation, external version, spinal anaesthesia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pregnant nulliparous women.
  • Breech presentation of fetus, eligible for external version.

Exclusion Criteria:

  • Unwilling to participate.
  • Unable to understand written and oral Swedish in the absence of interpreter.
  • Contraindications to spinal anaesthesia.

Sites / Locations

  • Skåne University Hospital
  • Skåne University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Standard treatment

Spinal anaesthesia

Arm Description

ECV according to standard practice.

ECV after low dose spinal anaesthesia (Bupivacain 2,5 mg plus Sufentanil 5 micrograms (µg)

Outcomes

Primary Outcome Measures

External version success rate
Rate of successful version as assessed by gynaecologist after maximum three attempts.

Secondary Outcome Measures

Overall maternal satisfaction post external version attempt
Evaluation of overall participant satisfaction using an online assessment questionnaire within an hour from the external version attempts.
Overall maternal satisfaction post partum
Evaluation of overall participant satisfaction using an online assessment questionnaire within 3 months from the external version attempts (within 2 months post partum)
Caesarian section rate
The mode of delivery, assessed from the medical charts after delivery.

Full Information

First Posted
January 7, 2019
Last Updated
October 25, 2022
Sponsor
Region Skane
search

1. Study Identification

Unique Protocol Identification Number
NCT03797833
Brief Title
Spinal Anesthesia for External Cephalic Version
Official Title
Spinal Anesthesia for External Cephalic Version in Nulliparous Women, A Controlled Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Suspended
Why Stopped
Slow inclusion rate. Central contact person quit for another job.
Study Start Date
January 7, 2019 (Actual)
Primary Completion Date
January 31, 2029 (Anticipated)
Study Completion Date
June 30, 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Region Skane

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study evaluates the potential benefits of spinal anaesthesia for nulliparous mothers scheduled for external version of babies in breech position.
Detailed Description
Fetuses in breech position are almost always delivered by Caesarian section (CS). If the fetus is in breech position by the end of pregnancy, attempts for external cephalic version (ECV) are usually made. The success rate of ECV in nulliparous women is lower than in multiparous women. There are studies showing a higher rate of successful ECV's if the mother received a low dose spinal anaesthesia (SA). Overall maternal satisfaction was higher with SA. These studies, however, did not take parity into account. The primary aim of this study is to see if SA can increase the rate of successful ECV's in nulliparous women. The secondary aims are to evaluate if maternal satisfaction increases and if the rate of CS is decreasing using SA during ECV.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breech Presentation; Before Labor
Keywords
breech presentation, external version, spinal anaesthesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard treatment
Arm Type
No Intervention
Arm Description
ECV according to standard practice.
Arm Title
Spinal anaesthesia
Arm Type
Active Comparator
Arm Description
ECV after low dose spinal anaesthesia (Bupivacain 2,5 mg plus Sufentanil 5 micrograms (µg)
Intervention Type
Procedure
Intervention Name(s)
Spinal Anaesthesia
Intervention Description
Spinal anaesthesia with Bupivacain 2.5 mg and Sufentanil 5 µg
Primary Outcome Measure Information:
Title
External version success rate
Description
Rate of successful version as assessed by gynaecologist after maximum three attempts.
Time Frame
1 hour
Secondary Outcome Measure Information:
Title
Overall maternal satisfaction post external version attempt
Description
Evaluation of overall participant satisfaction using an online assessment questionnaire within an hour from the external version attempts.
Time Frame
1 hour
Title
Overall maternal satisfaction post partum
Description
Evaluation of overall participant satisfaction using an online assessment questionnaire within 3 months from the external version attempts (within 2 months post partum)
Time Frame
3 months
Title
Caesarian section rate
Description
The mode of delivery, assessed from the medical charts after delivery.
Time Frame
1 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant nulliparous women. Breech presentation of fetus, eligible for external version. Exclusion Criteria: Unwilling to participate. Unable to understand written and oral Swedish in the absence of interpreter. Contraindications to spinal anaesthesia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas Herbst, MD PhD
Organizational Affiliation
Lund University, IKVL gyn/ob . Skåne University Hospital, Lund Sweden
Official's Role
Principal Investigator
Facility Information:
Facility Name
Skåne University Hospital
City
Lund
Country
Sweden
Facility Name
Skåne University Hospital
City
Malmö
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
25962611
Citation
Khaw KS, Lee SW, Ngan Kee WD, Law LW, Lau TK, Ng FF, Leung TY. Randomized trial of anaesthetic interventions in external cephalic version for breech presentation. Br J Anaesth. 2015 Jun;114(6):944-50. doi: 10.1093/bja/aev107. Epub 2015 May 10.
Results Reference
background
PubMed Identifier
27131581
Citation
Magro-Malosso ER, Saccone G, Di Tommaso M, Mele M, Berghella V. Neuraxial analgesia to increase the success rate of external cephalic version: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2016 Sep;215(3):276-86. doi: 10.1016/j.ajog.2016.04.036. Epub 2016 Apr 27. Erratum In: Am J Obstet Gynecol. 2017 Mar;216(3):315.
Results Reference
background
PubMed Identifier
25674710
Citation
Cluver C, Gyte GM, Sinclair M, Dowswell T, Hofmeyr GJ. Interventions for helping to turn term breech babies to head first presentation when using external cephalic version. Cochrane Database Syst Rev. 2015 Feb 9;2015(2):CD000184. doi: 10.1002/14651858.CD000184.pub4.
Results Reference
background
PubMed Identifier
28723831
Citation
Chalifoux LA, Bauchat JR, Higgins N, Toledo P, Peralta FM, Farrer J, Gerber SE, McCarthy RJ, Sullivan JT. Effect of Intrathecal Bupivacaine Dose on the Success of External Cephalic Version for Breech Presentation: A Prospective, Randomized, Blinded Clinical Trial. Anesthesiology. 2017 Oct;127(4):625-632. doi: 10.1097/ALN.0000000000001796.
Results Reference
background

Learn more about this trial

Spinal Anesthesia for External Cephalic Version

We'll reach out to this number within 24 hrs